期刊文献+

阿伐他汀对老年急性肾损伤患者临床疗效的影响观察 被引量:3

An Observation on the Effect of Atorvastatin on Elderly Patients with Acute Kidney Injury
下载PDF
导出
摘要 目的:研究分析他汀类药物治疗老年急性肾损伤患者的临床效果.方法:选取2012年11月-2014年11月收治的老年急性肾损伤患者102例,随机分为A、B、C3组,每组34例,A组给予20mg阿托伐他汀治疗,B组给予40mg阿托伐他汀治疗,C组给予常规治疗,对比3组临床效果.结果:B组Scr、TC、TG水平下降程度与A、C两组相比,差异显著(P 〈0.05);治疗后,3组细胞因子水平均显著低于治疗前,差异显著(P 〈0.05);B组细胞因子水平下降程度显著优于A、C组,差异显著(P 〈0.05).结论:较大剂量他汀类药物治疗老年急性肾损伤具有显著的临床效果,值得推广. Objective:To Analyze the clinical effects of statins on elderly patients with acute kidney inju-ry.Methods:Select 102 elderly patients with acute kidney injury deceived during the period from November 2012 to November 2014 and randomly divided into them into group A,group B,and group ,with 34 cases in each group,group A was treated with 20mg of atorvastatin ,group B received 40mg of atorvastatin ,group C received conventional therapy,compare the clinical effect in the three groups.Results:To compare the de-creasing level of Scr,TC,TG were obvious in group B with that in groupA,and group C ,the difference was significant (P<0.05);After treatment,the level of cytokine of the 3 groups was significantly lower than before ,the difference was significant (P<0.05);the decreasing of cytokine in group B was significantly bet-ter than that in group A and group C,the differences were significant (P<0.05).Conclusion:It is effective to treat elderly patients with acute kidney inj ury with relatively large dosage of statins,it is worthy of clinical promotion.
作者 徐凤云
出处 《数理医药学杂志》 2015年第11期1710-1711,共2页 Journal of Mathematical Medicine
关键词 他汀类药物 老年急性肾损伤 临床疗效 statins elderly patients with acute kidney injury clinical efficacy
  • 相关文献

参考文献6

二级参考文献144

  • 1赵新生,王鑫.正确评价多巴胺在重症患者中的使用[J].中国医刊,2004,39(8):18-21. 被引量:10
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:706
  • 3汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
  • 4Liistro F, Falsini G,Bolognese L.The clinical burden of contrast media-induced nephropathy[J].Ital Heart J,2003,4(10):668. 被引量:1
  • 5Goldenberg S,Matetzky.Nephropathy induced by contrast media:pathogenesis,risk factors and preventive strategies[J].Can Med Assoc,2005,172(11):1461. 被引量:1
  • 6I Tumlin J,Stacul F, Adam A,et al.Pathophysiology of contrastinduced nephropathy[J].Am J Cardio,2006,98(6A): 14. 被引量:1
  • 7Patti G,Nusca A,Chello M,et al.Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention[J]. AmJ Cardiol,2008,101 (3):279. 被引量:1
  • 8Jo SH,Koo BK,Park JS,et al.Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography(PROMISS) trial-arandomized controlled study[J].Am Heart J,2008,155(3):499. 被引量:1
  • 9Ichiki T, Takeda K,Tokunou T, et al.Downregulation of angiotensin 1I type 1 receptor by hydrophobic 3-hydroxy-3methylglutary 1 coenzyme A reductase inhibitors in vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol,2001,21 (12): 1896. 被引量:1
  • 10Dulak J,Loboda A,Jazwa A,et al.Atorvastatin affects several angiogenic mediators in human endothelial cells[J]. Endothelium,2005,12(2):233. 被引量:1

共引文献30

同被引文献23

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部